Artrya Limited AYA.AX Stock
Artrya Limited Price Chart
Artrya Limited AYA.AX Financial and Trading Overview
Artrya Limited stock price | 0.38 AUD |
Previous Close | 0.22 AUD |
Open | 0.22 AUD |
Bid | 0.21 AUD x N/A |
Ask | 0.22 AUD x N/A |
Day's Range | 0.21 - 0.22 AUD |
52 Week Range | 0.2 - 0.95 AUD |
Volume | 9.67K AUD |
Avg. Volume | 104.73K AUD |
Market Cap | 16.46M AUD |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.15 AUD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AYA.AX Valuation Measures
Enterprise Value | -8643122 AUD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.46874997 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | 0.518 |
Trading Information
Artrya Limited Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -53.26% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.95 AUD |
52 Week Low | 0.2 AUD |
50-Day Moving Average | 0.24 AUD |
200-Day Moving Average | 0.43 AUD |
AYA.AX Share Statistics
Avg. Volume (3 month) | 104.73K AUD |
Avg. Daily Volume (10-Days) | 54K AUD |
Shares Outstanding | 78.4M |
Float | 46.14M |
Short Ratio | N/A |
% Held by Insiders | 38.85% |
% Held by Institutions | 5.69% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -24.80% |
Return on Equity (ttm) | -41.55% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | 0.003 AUD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | -6324000 AUD |
EBITDA | -16700000 AUD |
Net Income Avi to Common (ttm) | -16972000 AUD |
Diluted EPS (ttm) | -0.23 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 27.13M AUD |
Total Cash Per Share (mrq) | 0.35 AUD |
Total Debt (mrq) | 1.23M AUD |
Total Debt/Equity (mrq) | 3.51 AUD |
Current Ratio (mrq) | 17.737 |
Book Value Per Share (mrq) | 0.448 |
Cash Flow Statement
Operating Cash Flow (ttm) | -11049000 AUD |
Levered Free Cash Flow (ttm) | -12977000 AUD |
Profile of Artrya Limited
Country | Australia |
State | WA |
City | West Perth |
Address | 1257 Hay Street |
ZIP | 6005 |
Phone | 61 8 6478 7816 |
Website | https://www.artrya.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. The company was incorporated in 2018 and is based in West Perth, Australia.
Q&A For Artrya Limited Stock
What is a current AYA.AX stock price?
Artrya Limited AYA.AX stock price today per share is 0.38 AUD.
How to purchase Artrya Limited stock?
You can buy AYA.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Artrya Limited?
The stock symbol or ticker of Artrya Limited is AYA.AX.
Which industry does the Artrya Limited company belong to?
The Artrya Limited industry is Health Information Services.
How many shares does Artrya Limited have in circulation?
The max supply of Artrya Limited shares is 78.7M.
What is Artrya Limited Price to Earnings Ratio (PE Ratio)?
Artrya Limited PE Ratio is now.
What was Artrya Limited earnings per share over the trailing 12 months (TTM)?
Artrya Limited EPS is -0.15 AUD over the trailing 12 months.
Which sector does the Artrya Limited company belong to?
The Artrya Limited sector is Healthcare.